AC
ETON icon

Aristides Capital’s Eton Pharmaceutcials ETON Stock Holding History

Aristides Capital’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.26M Sell
145,410
-40,631
-22% -$1.19M 1.02% 28
2026
Q1 		$4.59M Buy
186,041
+24,605
+15% +$430K 0.99% 26
2025
Q4 		$2.73M Sell
161,436
-6,151
-4% -$108K 0.48% 43
2025
Q3 		$3.64M Hold
167,587
– – 0.53% 38
2025
Q2 		$2.39M Sell
167,587
-74,000
-31% -$1.17M 0.47% 38
2025
Q1 		$3.14M Hold
241,587
– – 0.93% 29
2024
Q4 		$3.22M Buy
241,587
+41,587
+21% +$422K 0.66% 28
2024
Q3 		$1.2M Hold
200,000
– – 0.37% 60
2024
Q2 		$658K Buy
+200,000
New +$700K 0.19% 99

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return

Aristides Capital's ETON Position: Q2 2026 in Review

Aristides Capital reduced its Eton Pharmaceutcials (ETON) stake by 22% in Q2 2026, selling an estimated $1.19M and leaving 145,410 shares worth $5.26M. The position accounts for 1.02% of the portfolio, ranked #28.

Aristides Capital first reported a position in ETON in Q2 2024 and has held it in 9 quarters since. 165 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • Aristides Capital held 145,410 shares of Eton Pharmaceutcials worth $5.26M as of Q2 2026.
  • Aristides Capital sold 40,631 Eton Pharmaceutcials shares in Q2 2026, an estimated $1.19M.
  • Eton Pharmaceutcials made up 1.02% of Aristides Capital's portfolio in Q2 2026, its #28 holding.
  • Aristides Capital first reported a position in Eton Pharmaceutcials in Q2 2024 and has held it in 9 quarters since.
  • 165 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Aristides Capital's 13F filing for Q2 2026, filed 13 Aug 2026.